Unnamed: 0,title,date,stock,sentiment
1244195.0,"Tonix Pharmaceuticals Announces FUJIFILM Diosynth Biotechnologies to be the Manufacturing Partner for Tonix's Coronavirus Vaccine Candidate, TNX-1800",2020-06-01 07:06:00-04:00,TNXP,neutral
1244196.0,"Tonix Pharma Shares Follow Tweet From Company: 'Co-authored article by Dr. Lederman published in the journal, Vaccine, discusses early smallpox vaccine manufacturing in the US...'",2020-05-29 09:37:00-04:00,TNXP,positive
1244197.0,Tonix Pharmaceuticals Posts Results From Pharmacokinetic Analyses Of TNX-102 SL And TNX-601 CR In Advance Of Virtual Poster Presentations At American Society Of Clinical Psychopharmacology,2020-05-21 07:06:00-04:00,TNXP,neutral
1244198.0,Tonix Pharma Shares Spike Higher As Company Tweets Out Science Magazine Report,2020-05-19 14:55:00-04:00,TNXP,positive
1244199.0,'Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals' -Cell.com Article,2020-05-18 13:30:00-04:00,TNXP,neutral
1244200.0,Tonix Pharmaceuticals Q1 EPS $(0.370) Up From $(1.290) YoY,2020-05-12 07:31:00-04:00,TNXP,neutral
1244201.0,15 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-05-11 07:36:00-04:00,TNXP,neutral
1244202.0,"Tonix Pharmaceuticals Enters Into Research Collaboration And Exclusive License Agreement With University Of Alberta To Develop Novel Horsepox-Based Vaccines, TNX-1810, TNX-1820 And TNX-1830, For Prevention Of Coronavirus COVID-19",2020-05-07 07:38:00-04:00,TNXP,positive
1244203.0,20 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-05-07 07:32:00-04:00,TNXP,neutral
1244204.0,20 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-01 07:42:00-04:00,TNXP,neutral
1244205.0,32 Stocks Moving in Friday's Pre-Market Session,2020-05-01 07:15:00-04:00,TNXP,neutral
1244206.0,Tonix Pharma Reports Achieves 50% Enrollment In Phase 3 RELIEF Study Of TNX-102 SL For Mgmt. Of Fibromyalgia,2020-04-24 07:02:00-04:00,TNXP,positive
1244207.0,Tonix Pharma S-3 Shows Registration For $150M Mixed Securities Shelf Offering,2020-04-08 17:14:00-04:00,TNXP,positive
1244209.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus package boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 10:58:00-04:00,TNXP,positive
1244210.0,17 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-03-26 07:39:00-04:00,TNXP,neutral
1244211.0,88 Biggest Movers From Yesterday,2020-03-26 04:07:00-04:00,TNXP,neutral
1244212.0,62 Stocks Moving In Wednesday's Mid-Day Session,2020-03-25 12:16:00-04:00,TNXP,neutral
1244213.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-03-25 07:35:00-04:00,TNXP,neutral
1244214.0,"The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down",2020-03-25 07:29:00-04:00,TNXP,neutral
1244215.0,30 Stocks Moving in Wednesday's Pre-Market Session,2020-03-25 07:08:00-04:00,TNXP,neutral
1244216.0,Tonix Pharmaceuticals Q4 EPS $(2.86) Up From $(6.1) YoY,2020-03-24 17:20:00-04:00,TNXP,neutral
1244217.0,105 Biggest Movers From Friday,2020-03-23 05:21:00-04:00,TNXP,neutral
1244218.0,Mid-Afternoon Market Update: Dow Tumbles Over 600 Points; Bellerophon Therapeutics Shares Surge,2020-03-20 14:56:00-04:00,TNXP,positive
1244219.0,Mid-Day Market Update: Crude Oil Down Over 10%; GenMark Diagnostics Shares Spike Higher,2020-03-20 12:18:00-04:00,TNXP,negative
1244220.0,70 Stocks Moving In Friday's Mid-Day Session,2020-03-20 12:02:00-04:00,TNXP,neutral
1244221.0,Tonix Pharmaceuticals shares are trading higher after the company's 8-K showed it would present certain info related to the TNX-1800 for potential a coronavirus vaccine to the World Health Organization on Friday.,2020-03-20 08:31:00-04:00,TNXP,positive
1244222.0,Tonix Pharma 8-K Shows Co. To Present Certain Info Related To TNX-1800 For Potential Coronavirus Vaccine To WHO On Fri.,2020-03-20 08:05:00-04:00,TNXP,positive
1244223.0,8 Biotechs With Coronavirus Vaccines In Development,2020-03-16 10:42:00-04:00,TNXP,neutral
1244224.0,52 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-09 08:04:00-04:00,TNXP,neutral
1244225.0,28 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-03-05 07:51:00-05:00,TNXP,neutral
1244226.0,Shares of several vaccine-related companies are trading lower potentially on profit-taking following large rallies in the sector from the continued spread of the coronavirus.,2020-03-03 10:57:00-05:00,TNXP,neutral
1244227.0,40 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-03-03 08:10:00-05:00,TNXP,neutral
1244228.0,108 Biggest Movers From Yesterday,2020-03-03 04:57:00-05:00,TNXP,neutral
1244229.0,How The COVID-19 Outbreak Is Benefiting Biotech Investors,2020-03-02 14:27:00-05:00,TNXP,neutral
1244230.0,55 Stocks Moving In Monday's Mid-Day Session,2020-03-02 11:52:00-05:00,TNXP,neutral
1244231.0,Shares of multiple vaccine and immune defense companies are trading higher on continued coronavirus fears.,2020-03-02 09:27:00-05:00,TNXP,positive
1244232.0,30 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-02 07:41:00-05:00,TNXP,neutral
1244233.0,30 Stocks Moving in Monday's Pre-Market Session,2020-03-02 07:21:00-05:00,TNXP,neutral
1244234.0,140 Biggest Movers From Friday,2020-03-02 04:43:00-05:00,TNXP,neutral
1244235.0,86 Stocks Moving In Friday's Mid-Day Session,2020-02-28 12:19:00-05:00,TNXP,negative
1244236.0,Tonix Pharmaceuticals Prices $16M Common Stock Offering At $1.10/Share,2020-02-28 08:47:00-05:00,TNXP,neutral
1244237.0,46 Stocks Moving in Friday's Pre-Market Session,2020-02-28 07:39:00-05:00,TNXP,neutral
1244238.0,Shares of several vaccine and immune defense companies are trading higher on renewed coronavirus fears. NOTE: A Coronavirus patient in Japan who had recovered from the virus tested positive for a second time raising concerns.,2020-02-27 08:37:00-05:00,TNXP,positive
1244239.0,"Benzinga Pro's Top 5 Stocks To Watch For Thurs., Feb. 27, 2020: MSFT, JCP, APT, BBY, TNXP",2020-02-27 07:58:00-05:00,TNXP,positive
1244240.0,28 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-02-27 07:40:00-05:00,TNXP,neutral
1244241.0,95 Biggest Movers From Yesterday,2020-02-27 05:18:00-05:00,TNXP,neutral
1244242.0,Mid-Afternoon Market Update: Dow Turns Negative; SmileDirectClub Shares Fall On Downbeat Q4 Results,2020-02-26 14:53:00-05:00,TNXP,negative
1244243.0,75 Stocks Moving In Wednesday's Mid-Day Session,2020-02-26 12:18:00-05:00,TNXP,neutral
1244244.0,Mid-Day Market Update: Dow Jumps Over 400 Points; Menlo Therapeutics Shares Plunge,2020-02-26 12:02:00-05:00,TNXP,positive
1244245.0,"Tonix To Develop Vaccine Against COVID-19 Virus, Shares Surge",2020-02-26 09:46:00-05:00,TNXP,positive
1244246.0,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",2020-02-26 09:36:00-05:00,TNXP,negative
1244247.0,Tonix Pharmaceuticals shares are trading higher after the company announced a research collaboration with Southern Research to develop a potential vaccine against the coronavirus.,2020-02-26 09:01:00-05:00,TNXP,positive
1244248.0,24 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-02-26 08:01:00-05:00,TNXP,neutral
1244249.0,Tonix Pharmaceuticals Announces Research Collaboration With Southern Research To Develop Potential Vaccine To Protect Against New Coronavirus Disease 2019 (COVID-19) Based On Horsepox Virus (TNX-1800),2020-02-26 07:26:00-05:00,TNXP,positive
1244250.0,44 Stocks Moving in Wednesday's Pre-Market Session,2020-02-26 07:20:00-05:00,TNXP,neutral
1244251.0,"The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement",2020-02-25 08:28:00-05:00,TNXP,negative
1244252.0,22 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-02-20 07:56:00-05:00,TNXP,neutral
1244253.0,50 Stocks Moving in Thursday's Pre-Market Session,2020-02-20 07:30:00-05:00,TNXP,neutral
1244254.0,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",2020-02-20 07:06:00-05:00,TNXP,negative
1244255.0,"The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA",2020-02-19 07:21:00-05:00,TNXP,negative
1244256.0,Stocks That Hit 52-Week Lows On Tuesday,2020-02-18 11:11:00-05:00,TNXP,negative
1244257.0,Tonix Pharmaceuticals Announces Closing of $7.5 Million Public Offering,2020-02-11 16:01:00-05:00,TNXP,neutral
1244258.0,Stocks That Hit 52-Week Lows On Tuesday,2020-02-11 11:05:00-05:00,TNXP,negative
1244259.0,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",2020-02-11 07:23:00-05:00,TNXP,positive
1244260.0,Stocks That Hit 52-Week Lows On Monday,2020-02-10 10:28:00-05:00,TNXP,negative
1244261.0,12 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-02-10 07:51:00-05:00,TNXP,neutral
1244262.0,8 Biotechnology Stocks Moving In Monday's Pre-Market Session,2020-02-10 07:50:00-05:00,TNXP,neutral
1244263.0,95 Biggest Movers From Friday,2020-02-10 05:20:00-05:00,TNXP,neutral
1244264.0,Sabby Management Shows a 9.9% Passive Stake in Tonix Pharma,2020-02-07 14:04:00-05:00,TNXP,positive
1244265.0,Tonix Pharmaceuticals shares are trading lower after the company priced its $7.5 million common stock offering.,2020-02-07 10:00:00-05:00,TNXP,neutral
1244266.0,Tonix Pharmaceuticals Prices $7.5M Common Stock Offering,2020-02-07 08:50:00-05:00,TNXP,neutral
1244267.0,16 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-02-07 07:39:00-05:00,TNXP,neutral
1244268.0,10 Biotechnology Stocks Moving In Friday's Pre-Market Session,2020-02-07 07:35:00-05:00,TNXP,neutral
1244269.0,"The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns",2020-02-07 07:32:00-05:00,TNXP,negative
1244270.0,46 Stocks Moving in Friday's Pre-Market Session,2020-02-07 07:25:00-05:00,TNXP,neutral
1244271.0,100 Biggest Movers From Yesterday,2020-02-07 04:30:00-05:00,TNXP,neutral
1244272.0,Mid-Afternoon Market Update: Dow Rises Over 100 Points; Glu Mobile Shares Spike Higher,2020-02-06 14:28:00-05:00,TNXP,positive
1244273.0,74 Stocks Moving In Thursday's Mid-Day Session,2020-02-06 12:38:00-05:00,TNXP,neutral
1244274.0,Mid-Day Market Update: GasLog Partners Falls Following Q4 Results; Unisys Shares Climb,2020-02-06 12:07:00-05:00,TNXP,positive
1244275.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-06 10:53:00-05:00,TNXP,negative
1244276.0,Tonix Pharmaceuticals shares are trading lower after the company reported the enrollment for its Phase 3 RECOVERY study of Tonmya was stopped due to 'inadequate separation from placebo at week-12 based on interim analysis results of the first 50% of enrolled participants'.,2020-02-06 09:11:00-05:00,TNXP,negative
1244277.0,"The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs",2020-02-06 07:47:00-05:00,TNXP,negative
1244278.0,5 Biotechnology Stocks Moving In Thursday's Pre-Market Session,2020-02-06 07:34:00-05:00,TNXP,neutral
1244279.0,10 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-02-06 07:32:00-05:00,TNXP,neutral
1244280.0,44 Stocks Moving in Thursday's Pre-Market Session,2020-02-06 07:26:00-05:00,TNXP,neutral
1244281.0,"Tonix Pharma Shares Resume Trade, Down 60%",2020-02-05 17:53:00-05:00,TNXP,positive
1244282.0,Tonix Pharma Shares To Resume Trade At 5:45 p.m. EST,2020-02-05 17:29:00-05:00,TNXP,positive
1244283.0,"UPDATE: Tonix Pharma Says Co. Is Currently Enrolling Phase 3 Study Of TNX-102 In Fibromyalgia Syndrome, Sees Interim Results In Q3",2020-02-05 17:17:00-05:00,TNXP,neutral
1244284.0,"UPDATE: Tonix Says Plans To Unblind, Report Top-Line Results For Tonmya Trial In Q2",2020-02-05 17:17:00-05:00,TNXP,neutral
1244285.0,Tonix Pharma Reports Enrollment For RECOVERY Study Of Tonmya Was Stopped Due To 'Inadequate Separation from Placebo at Week-12 Based on Interim Analysis Results of the First 50% of Enrolled Participants',2020-02-05 17:16:00-05:00,TNXP,negative
1244286.0,Tonix Pharma Shares Halted News Pending,2020-02-05 17:13:00-05:00,TNXP,positive
1244287.0,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance",2020-01-30 09:26:00-05:00,TNXP,positive
1244288.0,Tonix Pharma Highlights Results From Preclinical Study Of TNX-801 At ASM Conference,2020-01-29 16:30:00-05:00,TNXP,neutral
1244289.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-01-27 07:40:00-05:00,TNXP,neutral
1244290.0,14 Biotechnology Stocks Moving In Monday's Pre-Market Session,2020-01-27 07:38:00-05:00,TNXP,neutral
1244291.0,70 Biggest Movers From Friday,2020-01-27 04:02:00-05:00,TNXP,neutral
1244292.0,44 Stocks Moving In Friday's Mid-Day Session,2020-01-24 12:08:00-05:00,TNXP,neutral
1244293.0,Mid-Morning Market Update: Markets Mostly Higher; American Express Earnings Top Expectations,2020-01-24 10:18:00-05:00,TNXP,positive
1244294.0,4 Biotechnology Stocks Moving In Friday's Pre-Market Session,2020-01-24 07:40:00-05:00,TNXP,neutral
1244295.0,6 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-01-24 07:35:00-05:00,TNXP,neutral
1244296.0,Tonix Pharmaceuticals shares are trading higher after the company announced it has completed the required fed-fasting and dose proportionality tests of TNX-102.,2020-01-24 07:27:00-05:00,TNXP,positive
1244297.0,"Tonix Pharma Reports Successful Completion Of Fed-Fasting, Dose Proportionality Study Of TNX-102 SL",2020-01-24 07:01:00-05:00,TNXP,positive
1244298.0,146 Biotechnology Stocks Moving In Thursday's Session,2020-01-23 12:47:00-05:00,TNXP,neutral
1244299.0,82 Biggest Movers From Yesterday,2020-01-22 04:18:00-05:00,TNXP,neutral
1244300.0,Mid-Afternoon Market Update: CSS Industries Surges Following Acquisition News; Advaxis Shares Slide,2020-01-21 15:05:00-05:00,TNXP,positive
1244301.0,55 Stocks Moving In Tuesday's Mid-Day Session,2020-01-21 12:14:00-05:00,TNXP,neutral
1244302.0,Mid-Day Market Update: Dow Falls Over 100 Points; Genprex Shares Spike Higher,2020-01-21 12:07:00-05:00,TNXP,positive
1244303.0,Tonix Pharmaceuticals shares are trading lower after the company filed for an offering of 3.2 million shares of its common stock.,2020-01-21 08:46:00-05:00,TNXP,positive
1244304.0,20 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-01-21 07:57:00-05:00,TNXP,neutral
1244305.0,Tonix Pharmaceuticals Holding Corp Files Preliminary Prospectus For Offering Of 3.2M Shares Of Common Stock,2020-01-21 07:15:00-05:00,TNXP,positive
1244306.0,48 Stocks Moving In Tuesday's Mid-Day Session,2020-01-14 12:06:00-05:00,TNXP,neutral
1244307.0,Tonix Pharmaceuticals shares are trading higher on a potential rebound following a ~15% dip over the past 2 trading sessions.,2020-01-14 08:54:00-05:00,TNXP,positive
1244308.0,Tonix Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.,2020-01-07 09:02:00-05:00,TNXP,positive
1244309.0,20 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-01-07 07:53:00-05:00,TNXP,neutral
1244310.0,Tonix Pharmaceuticals shares are trading lower potentially on profit-taking. The stock rallied roughly 16% after the company outlined a plan to develop TNX-601 tablets.,2019-12-17 11:48:00-05:00,TNXP,neutral
1244311.0,Tonix Pharma Outlines Plan To Develop TNX-601 Tablets As Once-Daily Treatment For Major Depressive Disorder,2019-12-16 15:16:00-05:00,TNXP,negative
1244313.0,51 Biggest Movers From Yesterday,2019-12-13 04:12:00-05:00,TNXP,neutral
1244314.0,Mid-Afternoon Market Update: Dow Up 200 Points; RiceBran Technologies Shares Plunge,2019-12-12 14:38:00-05:00,TNXP,positive
1244315.0,38 Stocks Moving In Thursday's Mid-Day Session,2019-12-12 12:11:00-05:00,TNXP,neutral
1244316.0,Mid-Day Market Update: Crude Oil Up Over 1%; Tonix Pharmaceuticals Shares Spike Higher,2019-12-12 11:58:00-05:00,TNXP,negative
1244317.0,"The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win",2019-12-12 07:38:00-05:00,TNXP,positive
1244318.0,13 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-12-12 07:37:00-05:00,TNXP,neutral
1244319.0,18 Stocks Moving in Thursday's Pre-Market Session,2019-12-12 07:32:00-05:00,TNXP,neutral
1244320.0,Tonix Pharmaceuticals shares are trading higher after the company announced a new European patent for composition and formulation of TNX-102 SL. The patent will provide the company with market exclusivity until 2034.,2019-12-12 07:24:00-05:00,TNXP,positive
1244321.0,"A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Initial Jobless Claims, Producer Prices Data",2019-12-12 06:40:00-05:00,TNXP,neutral
1244322.0,6 Stocks Moving In Wednesday's After-Hours Session,2019-12-11 16:36:00-05:00,TNXP,neutral
1244323.0,Tonix Pharmaceuticals shares are trading higher after the company announced a new European patent for composition and formulation of TNX-102 SL. The patent will provide the company with market exclusivity until 2034.,2019-12-11 16:18:00-05:00,TNXP,positive
1244324.0,Tonix Pharmaceuticals Announces New European Patent For Composition And Formulation Of TNX-102 SL; Patent Provides Co. With Market Exclusivity Until 2034,2019-12-11 16:06:00-05:00,TNXP,neutral
1244325.0,Stocks That Hit 52-Week Lows On Wednesday,2019-12-11 10:55:00-05:00,TNXP,negative
1244326.0,"The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",2019-12-11 07:21:00-05:00,TNXP,negative
1244327.0,Stocks That Hit 52-Week Lows On Tuesday,2019-12-10 14:29:00-05:00,TNXP,negative
1244328.0,41 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-10 08:10:00-05:00,TNXP,neutral
1244329.0,"The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares",2019-12-10 07:56:00-05:00,TNXP,positive
1244330.0,Tonix Pharmaceuticals Enrolls First Patient In Phase 3 RELIEF Study Of TNX-102 SL For Management Of Fibromyalgia,2019-12-10 07:08:00-05:00,TNXP,positive
1244331.0,Stocks That Hit 52-Week Lows On Friday,2019-12-06 12:04:00-05:00,TNXP,negative
1244332.0,Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement,2019-12-03 07:08:00-05:00,TNXP,neutral
1244333.0,52 Biggest Movers From Wednesday,2019-11-29 05:26:00-05:00,TNXP,neutral
1244334.0,33 Stocks Moving In Wednesday's Mid-Day Session,2019-11-27 11:41:00-05:00,TNXP,neutral
1244335.0,"The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen",2019-11-27 07:26:00-05:00,TNXP,negative
1244336.0,18 Stocks Moving in Wednesday's Pre-Market Session,2019-11-27 07:16:00-05:00,TNXP,neutral
1244337.0,4 Stocks Moving In Tuesday's After-Hours Session,2019-11-26 17:47:00-05:00,TNXP,neutral
1244338.0,Tonix Pharmaceuticals shares are trading higher after the company announced it received the official minutes from the Breakthrough Therapy Type B Clinical Guidance meeting with the FDA for Tonmya. The minutes are consistent with guidance received at the meeting.,2019-11-26 16:21:00-05:00,TNXP,positive
1244339.0,Tonix Pharmaceuticals Announces Receipt Of FDA Official Minutes From Breakthrough Therapy Type B Clinical Guidance Meeting For Tonmya As Potential New Treatment For PTSD ; Says Minutes Are Consistent With Guidance Received At FDA Meeting,2019-11-26 16:13:00-05:00,TNXP,neutral
1244340.0,Stocks That Hit 52-Week Lows On Tuesday,2019-11-26 11:18:00-05:00,TNXP,negative
1244341.0,"The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate",2019-11-22 08:18:00-05:00,TNXP,positive
1244342.0,66 Biggest Movers From Yesterday,2019-11-22 04:50:00-05:00,TNXP,neutral
1244343.0,45 Stocks Moving In Thursday's Mid-Day Session,2019-11-21 12:11:00-05:00,TNXP,neutral
1244344.0,Stocks That Hit 52-Week Lows On Thursday,2019-11-21 11:09:00-05:00,TNXP,negative
1244345.0,Tonix Plans Regulatory Filing To Kick Off Study Of Alcohol Use Disorder Drug,2019-11-21 09:40:00-05:00,TNXP,negative
1244346.0,Tonix Pharma Reports Initiation Of Phase 3 RELIEF Study Of TNX-102 SL For Mgmt. Of Fibromyalgia,2019-11-21 08:03:00-05:00,TNXP,positive
1244347.0,22 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-11-21 07:47:00-05:00,TNXP,neutral
1244348.0,30 Stocks Moving in Thursday's Pre-Market Session,2019-11-21 07:38:00-05:00,TNXP,neutral
1244349.0,"The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon",2019-11-21 07:22:00-05:00,TNXP,positive
1244350.0,Tonix Pharmaceuticals shares are trading higher after the company announced it completed a pre-IND meeting with the FDA for TNX-102 SL.,2019-11-20 16:30:00-05:00,TNXP,positive
1244351.0,Tonix Pharma Reports Completed Pre-Investigational New Drug Meeting With FDA For TNX-102 SL,2019-11-20 16:07:00-05:00,TNXP,neutral
1244352.0,"The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout",2019-11-19 07:56:00-05:00,TNXP,neutral
1244353.0,66 Biggest Movers From Friday,2019-11-18 05:37:00-05:00,TNXP,neutral
1244354.0,41 Stocks Moving In Friday's Mid-Day Session,2019-11-15 12:15:00-05:00,TNXP,neutral
1244355.0,Stocks That Hit 52-Week Lows On Friday,2019-11-15 10:43:00-05:00,TNXP,negative
1244356.0,"Tonix Pharma Prices ~547.4K Class A Unit, Warrants Offering At $1.94/Unit, Gross Proceeds $9M",2019-11-15 08:33:00-05:00,TNXP,negative
1244357.0,30 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-15 08:14:00-05:00,TNXP,neutral
1244358.0,"The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval",2019-11-15 07:08:00-05:00,TNXP,negative
1244359.0,70 Biggest Movers From Yesterday,2019-11-15 05:29:00-05:00,TNXP,neutral
1244360.0,48 Stocks Moving In Thursday's Mid-Day Session,2019-11-14 12:18:00-05:00,TNXP,neutral
1244361.0,Stocks That Hit 52-Week Lows On Thursday,2019-11-14 11:11:00-05:00,TNXP,negative
1244362.0,81 Biggest Movers From Yesterday,2019-11-14 05:20:00-05:00,TNXP,neutral
1244363.0,74 Biggest Movers From Yesterday,2019-11-13 04:42:00-05:00,TNXP,neutral
1244364.0,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat",2019-11-12 07:20:00-05:00,TNXP,neutral
1244365.0,58 Biggest Movers From Yesterday,2019-11-12 04:25:00-05:00,TNXP,neutral
1244366.0,38 Stocks Moving In Monday's Mid-Day Session,2019-11-11 12:10:00-05:00,TNXP,neutral
1244367.0,Tonix Pharmaceuticals Q3 EPS $(5.69) Misses $(4.35) Estimate,2019-11-08 16:49:00-05:00,TNXP,negative
1244368.0,Stocks That Hit 52-Week Lows On Friday,2019-11-08 11:41:00-05:00,TNXP,negative
1244369.0,"The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut",2019-11-08 08:14:00-05:00,TNXP,neutral
1244370.0,94 Biggest Movers From Yesterday,2019-11-08 06:01:00-05:00,TNXP,neutral
1244371.0,75 Stocks Moving In Thursday's Mid-Day Session,2019-11-07 12:19:00-05:00,TNXP,neutral
1244372.0,46 Biggest Movers From Yesterday,2019-11-05 04:45:00-05:00,TNXP,neutral
1244373.0,35 Stocks Moving In Monday's Mid-Day Session,2019-11-04 13:37:00-05:00,TNXP,neutral
1244374.0,Mid-Day Market Update: Wright Medical Group Surges Following Acquisition News; Ceragon Networks Shares Plunge,2019-11-04 13:10:00-05:00,TNXP,positive
1244375.0,Mid-Morning Market Update: Markets Open Higher; Sysco Reports Mixed Q1 Results,2019-11-04 10:26:00-05:00,TNXP,neutral
1244376.0,"Tonix Pharma Shares Resume Trade, Down 12.7% For Session",2019-11-04 09:52:00-05:00,TNXP,positive
1244377.0,21 Stocks Moving In Monday's Pre-Market Session,2019-11-04 07:56:00-05:00,TNXP,neutral
1244378.0,Tonix Pharma Moves the Timing of its Primary Endpoint From Week 4 to Week 12,2019-11-04 07:27:00-05:00,TNXP,neutral
1244379.0,58 Biggest Movers From Friday,2019-11-04 07:12:00-05:00,TNXP,neutral
1244380.0,Stocks That Hit 52-Week Lows On Friday,2019-11-01 11:13:00-04:00,TNXP,negative
1244381.0,"Tonix Pharma Reports 1-For-10 Reverse Split, Effective Market Open Fri., Nov. 1, 2019",2019-10-31 13:02:00-04:00,TNXP,positive
1244382.0,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study",2019-10-29 07:32:00-04:00,TNXP,positive
1244383.0,33 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-23 08:48:00-04:00,TNXP,neutral
1244384.0,"The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics' Lukewarm Breast Cancer Data",2019-10-23 07:54:00-04:00,TNXP,negative
1244385.0,"Tonix Pharmaceuticals Announces Issuance Of US Patent For Crystalline Tianeptine Oxalate Salt, The Active Ingredient Of TNX-601",2019-10-23 07:22:00-04:00,TNXP,positive
1244386.0,Tonix Pharma Announces the European Patent Office Upheld its Patent for the Treatment of PTSD,2019-10-07 07:05:00-04:00,TNXP,neutral
1244387.0,Tonix Pharma Reports Completion Of Long-Term Exposure Studies in Participants with PTSD to Evaluate the Tolerability of TNX-102 SL 5.6 mg,2019-10-03 08:25:00-04:00,TNXP,neutral
1244388.0,15 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-09-20 08:24:00-04:00,TNXP,neutral
1244389.0,65 Biggest Movers From Yesterday,2019-09-18 06:53:00-04:00,TNXP,neutral
1244390.0,38 Stocks Moving In Tuesday's Mid-Day Session,2019-09-17 12:14:00-04:00,TNXP,neutral
1244391.0,9 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-09-17 08:13:00-04:00,TNXP,neutral
1244392.0,25 Stocks Moving in Tuesday's Pre-Market Session,2019-09-17 07:42:00-04:00,TNXP,neutral
1244393.0,"The Daily Biotech Pulse: Acceleron Shelves Muscular Dystrophy Drug Trial, Aclaris Aces Late-Stage Study",2019-09-17 07:23:00-04:00,TNXP,neutral
1244394.0,Tonix Pharmaceuticals shares are trading higher after the company announced a licensing agreement with Columbia University for the development of TXN-1700 for the treatment of gastric and pancreatic cancers.﻿,2019-09-17 07:16:00-04:00,TNXP,positive
1244395.0,A Peek Into The Markets: US Stock Futures Down Ahead Of Fed Meeting,2019-09-17 06:52:00-04:00,TNXP,neutral
1244396.0,"7 Stocks To Watch For September 17, 2019",2019-09-17 04:41:00-04:00,TNXP,neutral
1244397.0,Tonix Pharmaceuticals shares are trading higher after the company reported a licensing deal with Columbia University for the development of TXN-1700 for the treatment of Gastric.,2019-09-16 16:20:00-04:00,TNXP,positive
1244398.0,"Tonix Pharma Reports Licensing Deal With Columbia University For Development Of TNX-1700 For Treatment Of Gastric, Pancreatic Cancers",2019-09-16 16:16:00-04:00,TNXP,neutral
1244399.0,Tonix Pharma Highlights Publication Of Paper On TNX-1600 In European Journal Of Pharmacology,2019-09-16 07:10:00-04:00,TNXP,neutral
1244400.0,Tonix Pharmaceuticals Doses Participants In Phase 1 Study Evaluating TNX-601 For The Daytime Treatment Of Posttraumatic Stress Disorder,2019-09-04 07:14:00-04:00,TNXP,negative
1244401.0,Stocks That Hit 52-Week Lows On Monday,2019-08-26 10:28:00-04:00,TNXP,negative
1244402.0,"Tonix Pharmaceuticals And Massachusetts General Hospital Enter Into Research Collaboration To Develop Tonix's Third Generation Anti-CD154 Monoclonal Antibody, TNX-1500, For The Treatment And Prevention Of Organ Transplant Rejection",2019-08-21 07:05:00-04:00,TNXP,negative
1244403.0,55 Biggest Movers From Yesterday,2019-08-21 05:07:00-04:00,TNXP,neutral
1244404.0,44 Stocks Moving In Tuesday's Mid-Day Session,2019-08-20 12:21:00-04:00,TNXP,neutral
1244405.0,Mid-Morning Market Update: Markets Open Lower; Home Depot Earnings Beat Expectations,2019-08-20 10:18:00-04:00,TNXP,negative
1244406.0,22 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-08-20 08:32:00-04:00,TNXP,neutral
1244407.0,32 Stocks Moving in Tuesday's Pre-Market Session,2019-08-20 07:49:00-04:00,TNXP,neutral
1244408.0,Tonix Pharmaceuticals shares are trading higher after the company was granted an exclusive license from Wayne State University for technology and patents related TNX-1600.,2019-08-20 07:13:00-04:00,TNXP,positive
1244409.0,Tonix Pharmaceuticals Announces Exclusive Agreement To In-License TNX-1600 For PTSD,2019-08-20 07:04:00-04:00,TNXP,positive
1244410.0,Tonix Pharmaceuticals Q2 EPS $(0.95) Up From $(7.23) YoY,2019-08-12 08:05:00-04:00,TNXP,neutral
1244411.0,"The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering",2019-08-08 07:11:00-04:00,TNXP,neutral
1244412.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,TNXP,negative
1244413.0,"The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout",2019-08-07 07:34:00-04:00,TNXP,neutral
1244414.0,New 52-Week Lows for Tuesday Morning,2019-07-30 11:07:00-04:00,TNXP,negative
1244415.0,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings",2019-07-30 07:00:00-04:00,TNXP,positive
1244416.0,Stocks That Managed to Breach 52-Week Lows Friday,2019-07-26 15:45:00-04:00,TNXP,negative
1244417.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Screener Tool For Fri., July 26, 2019",2019-07-26 14:21:00-04:00,TNXP,positive
1244418.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Screener Tool For Thu., July 25, 2019",2019-07-25 13:42:00-04:00,TNXP,positive
1244419.0,Tonix Pharmaceuticals Announces Issuance of U.S. Patent for the Composition and Formulation of TNX-102 SL,2019-07-25 07:13:00-04:00,TNXP,neutral
1244420.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,TNXP,neutral
1244421.0,List of Companies Reaching Yearly Lows Tuesday,2019-07-23 14:58:00-04:00,TNXP,neutral
1244422.0,58 Biggest Movers From Yesterday,2019-07-17 04:59:00-04:00,TNXP,neutral
1244423.0,Mid-Afternoon Market Update: Crude Oil Down 4%; Cancer Genetics Shares Spike Higher,2019-07-16 14:42:00-04:00,TNXP,negative
1244424.0,Mid-Day Market Update: Blue Apron Jumps On Beyond Meat Partnership; Tonix Pharmaceuticals Shares Plummet,2019-07-16 12:36:00-04:00,TNXP,positive
1244425.0,41 Stocks Moving In Tuesday's Mid-Day Session,2019-07-16 12:10:00-04:00,TNXP,neutral
1244426.0,Mid-Morning Market Update: Markets Edge Lower; Goldman Sachs Tops Q2 Views,2019-07-16 10:24:00-04:00,TNXP,positive
1244427.0,Tonix Pharmaceuticals shares are trading lower after the company priced its common stock offering of 9 million shares at $0.60 per share.,2019-07-16 09:58:00-04:00,TNXP,positive
1244428.0,Tonix Pharmaceuticals Prices 9M Share Common Stock Offering At $0.60/Share,2019-07-16 08:37:00-04:00,TNXP,positive
1244429.0,Shares of several drug manufacturing companies are trading lower. The Trump Administration earlier rolled back a proposal to eliminate rebates from government drug plans and commented on continued efforts to lower drug prices.,2019-07-11 10:36:00-04:00,TNXP,negative
1244430.0,"The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV",2019-07-10 07:17:00-04:00,TNXP,positive
1244431.0,"The Daily Biotech Pulse: Roche Presents Positive Hemlibra Data, Amgen's Tender Offer For Nuevolution Complete, Genmab Offering",2019-07-09 07:11:00-04:00,TNXP,positive
1244432.0,"The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership",2019-06-25 07:15:00-04:00,TNXP,neutral
1244433.0,"Tonix Pharma Reports Issuance Of Patent In China For Composition, Formulation Of TNX-102 SL",2019-06-13 07:01:00-04:00,TNXP,neutral
1244434.0,Tonix Pharma Highlights Presentation Of Results From Pharmacokinetic Analyses Of TNX-102 In Poster Presentation At ASCPP,2019-05-30 08:08:00-04:00,TNXP,neutral
1244435.0,65 Biggest Movers From Yesterday,2019-05-29 05:10:00-04:00,TNXP,neutral
1244436.0,44 Stocks Moving In Tuesday's Mid-Day Session,2019-05-28 12:27:00-04:00,TNXP,neutral
1244437.0,33 Stocks Moving In Thursday's Mid-Day Session,2019-05-23 12:32:00-04:00,TNXP,neutral
1244438.0,Tonix Pharma To Present Results From Pharmacokinetic Analyses of TNX-102 SL in a Poster Presentation at the American Society of Clinical Psychopharmacology,2019-05-21 16:25:00-04:00,TNXP,neutral
1244439.0,"The Daily Biotech Pulse: Setback For Merck In Breast Cancer Study, Arrowhead to Join S&P SmallCap 600 Index, Ocular's Glaucoma Trial Fails",2019-05-21 07:40:00-04:00,TNXP,negative
1244440.0,Tonix Pharmaceuticals Q1 EPS $(1.29) Misses $(1.08) Estimate,2019-05-13 08:08:00-04:00,TNXP,negative
1244441.0,"Tonix Pharma Offers Update On Collaborative Research, Development Deal With US Army Medical Materiel Development Activity: Co. Received Notice Of Termination, Co. Says Does Not Affect Finances",2019-04-23 13:52:00-04:00,TNXP,neutral
1244442.0,26 Stocks Moving In Tuesday's Pre-Market Session,2019-04-23 08:26:00-04:00,TNXP,neutral
1244443.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Mon., Apr. 22, 2019",2019-04-22 10:22:00-04:00,TNXP,positive
1244444.0,30 Stocks Moving In Monday's Pre-Market Session,2019-04-22 08:16:00-04:00,TNXP,neutral
1244445.0,Tonix Pharma Announces the FDA Reinstates Breakthrough Therapy Designation for Tonmya,2019-04-22 07:03:00-04:00,TNXP,neutral
1244446.0,"Benzinga's Top Upgrades, Downgrades For April 18, 2019",2019-04-18 09:52:00-04:00,TNXP,positive
1244447.0,Roth Capital Upgrades Tonix Pharmaceuticals to Buy,2019-04-18 08:44:00-04:00,TNXP,neutral
1244448.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Fri., Apr. 5, 2019",2019-04-05 10:03:00-04:00,TNXP,positive
1244449.0,52 Biggest Movers From Yesterday,2019-04-05 05:55:00-04:00,TNXP,neutral
1244450.0,Mid-Afternoon Market Update: Dow Up 135 Points; Recro Pharma Shares Spike Higher,2019-04-04 14:36:00-04:00,TNXP,positive
1244451.0,44 Stocks Moving In Thursday's Mid-Day Session,2019-04-04 12:39:00-04:00,TNXP,neutral
1244452.0,Mid-Day Market Update: Resources Connection Falls After Q3 Results; Tonix Pharmaceuticals Shares Surge,2019-04-04 12:12:00-04:00,TNXP,positive
1244453.0,What's Driving The Rally In Nanocap Biotech Tonix Pharma?,2019-04-04 10:21:00-04:00,TNXP,neutral
1244454.0,Mid-Morning Market Update: Markets Open Higher; Constellation Brands Tops Q4 Estimates,2019-04-04 10:08:00-04:00,TNXP,positive
1244455.0,Tonix Pharmaceuticals Holding Corp shares are trading higher after the company reported the expansion of its TNX-102 SL 5.6 mg program beyond PTSD to include Phase 3 development for TNX-102 SL in fibromyalgia.,2019-04-04 09:50:00-04:00,TNXP,positive
1244456.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Thurs., Apr. 4, 2019",2019-04-04 09:45:00-04:00,TNXP,positive
1244457.0,Tonix Pharma Reports Expansion Of TNX-102 SL 5.6 mg Program Beyond PTSD To Include Phase 3 Development Fror TNX-102 SL In Fibromyalgia,2019-04-04 07:42:00-04:00,TNXP,neutral
1244458.0,Tonix Pharmaceuticals Q4 EPS $(6.10) Misses $(3.80) Estimate,2019-03-18 08:04:00-04:00,TNXP,negative
1244459.0,75 Biggest Movers From Friday,2019-03-18 05:22:00-04:00,TNXP,neutral
1244460.0,71 Biggest Movers From Yesterday,2019-03-15 05:24:00-04:00,TNXP,neutral
1244461.0,68 Biggest Movers From Yesterday,2019-03-14 05:22:00-04:00,TNXP,neutral
1244462.0,56 Biggest Movers From Yesterday,2019-03-13 06:04:00-04:00,TNXP,neutral
1244463.0,42 Stocks Moving In Tuesday's Mid-Day Session,2019-03-12 14:06:00-04:00,TNXP,neutral
1244464.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Tues., Mar. 12, 2019",2019-03-12 13:35:00-04:00,TNXP,positive
1244465.0,50 Biggest Movers From Yesterday,2019-03-12 05:04:00-04:00,TNXP,neutral
1244466.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Mar. 11, 2019",2019-03-11 15:36:00-04:00,TNXP,positive
1244467.0,40 Stocks Moving In Monday's Mid-Day Session,2019-03-11 12:02:00-04:00,TNXP,neutral
1244468.0,"Tonix Pharmaceuticals shares are trading higher after the company enrolled its first participant in its phase 3 'RECOVERY' trial, testing Tonmya for the treatment of PTSD.",2019-03-11 09:24:00-04:00,TNXP,positive
1244469.0,30 Stocks Moving In Monday's Pre-Market Session,2019-03-11 08:02:00-04:00,TNXP,neutral
1244470.0,70 Biggest Movers From Friday,2019-03-11 05:26:00-04:00,TNXP,neutral
1244471.0,50 Stocks Moving In Friday's Mid-Day Session,2019-03-08 12:31:00-05:00,TNXP,neutral
1244472.0,28 Stocks Moving In Friday's Pre-Market Session,2019-03-08 07:54:00-05:00,TNXP,neutral
1244473.0,Tonix Pharmaceuticals shares are trading higher after the company late Thursday announced a new European use patent for its TNX-601 PTSD treatment candidate.,2019-03-08 07:47:00-05:00,TNXP,positive
1244474.0,"The Daily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings",2019-03-08 07:38:00-05:00,TNXP,neutral
1244475.0,Tonix Pharmaceuticals Announces New European Use Patent For TNX-601,2019-03-07 16:17:00-05:00,TNXP,neutral
1244476.0,62 Biggest Movers From Yesterday,2019-03-05 05:19:00-05:00,TNXP,neutral
1244477.0,50 Stocks Moving In Monday's Mid-Day Session,2019-03-04 12:44:00-05:00,TNXP,neutral
1244478.0,30 Stocks Moving In Monday's Pre-Market Session,2019-03-04 08:02:00-05:00,TNXP,neutral
1244479.0,A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street,2019-03-04 06:56:00-05:00,TNXP,neutral
1244480.0,"5 Stocks To Watch For March 4, 2019",2019-03-04 05:36:00-05:00,TNXP,neutral
1244481.0,Tonix Pharmaceuticals shares are trading higher after the company announced a buyback of up to $2 million.,2019-03-01 16:07:00-05:00,TNXP,positive
1244482.0,Tonix Pharmaceuticals Reports Up To $2M Buyback,2019-03-01 16:00:00-05:00,TNXP,neutral
1244483.0,Tonix Pharma Shares Spike To Afternoon High Up 5.9% As Traders Circulate ClinicalTrials.gov Study Record Detail For Co.'s TNX-102 SL,2019-02-15 13:40:00-05:00,TNXP,positive
1244484.0,Tonix Pharmaceuticals Granted European patent number EP3246031 titled ;METHOD FOR TREATING NEUROCOGNITIVE DYSFUNCTION',2019-01-28 11:43:00-05:00,TNXP,negative
1244485.0,56 Biggest Movers From Yesterday,2019-01-15 04:57:00-05:00,TNXP,neutral
1244486.0,55 Biggest Movers From Monday,2018-12-26 04:38:00-05:00,TNXP,neutral
1244487.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,TNXP,neutral
1244488.0,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",2018-12-19 07:46:00-05:00,TNXP,positive
1244489.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,TNXP,positive
1244490.0,Tonix Pharmaceuticals Regains Compliance With NASDAQ Minimum Bid Price Requirement,2018-12-18 07:11:00-05:00,TNXP,neutral
1244491.0,"Tonix Pharma, Tenax Therapeutics 13G Filings From Iroquois Capital Show New 9.99% Stake",2018-12-14 15:48:00-05:00,TNXP,neutral
1244492.0,Tonix Pharma 13G Filing From CVI Investments Shows New 9.9% Stake,2018-12-14 12:05:00-05:00,TNXP,neutral
1244493.0,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",2018-12-11 08:22:00-05:00,TNXP,neutral
1244494.0,Tonix Pharmaceuticals Shares To Resume Trade At 11:05 a.m. EDT,2018-12-07 10:42:00-05:00,TNXP,positive
1244495.0,Tonix Pharma Prices $15M Offering At $3.50/Unit,2018-12-07 10:35:00-05:00,TNXP,neutral
1244496.0,Tonix Pharma Shares Halted News Pending,2018-12-07 10:20:00-05:00,TNXP,positive
1244497.0,"The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut",2018-12-07 08:04:00-05:00,TNXP,neutral
1244498.0,25 Stocks Moving In Friday's Pre-Market Session,2018-12-07 07:54:00-05:00,TNXP,neutral
1244499.0,Tonix Pharmaceuticals +179% Premarket,2018-12-07 06:38:00-05:00,TNXP,neutral
1244500.0,60 Biggest Movers From Yesterday,2018-12-07 04:42:00-05:00,TNXP,neutral
1244501.0,44 Stocks Moving In Thursday's Mid-Day Session,2018-12-06 13:49:00-05:00,TNXP,neutral
1244502.0,25 Stocks Moving In Tuesday's Pre-Market Session,2018-12-04 08:03:00-05:00,TNXP,neutral
1244503.0,56 Biggest Movers From Yesterday,2018-12-04 05:02:00-05:00,TNXP,neutral
1244504.0,Mid-Afternoon Market Update: Tesaro Climbs On Acquisition News; Tonix Pharmaceuticals Shares Slide,2018-12-03 14:30:00-05:00,TNXP,positive
1244505.0,46 Stocks Moving In Monday's Mid-Day Session,2018-12-03 12:37:00-05:00,TNXP,neutral
1244506.0,Mid-Day Market Update: Hexindai Falls After Q2 Results; Global Blood Therapeutics Shares Surge,2018-12-03 12:15:00-05:00,TNXP,positive
1244507.0,Tonix Pharma shares are trading lower after the company filed for a $34M stock and warrant offering.,2018-12-03 08:24:00-05:00,TNXP,neutral
1244508.0,28 Stocks Moving In Monday's Pre-Market Session,2018-12-03 08:13:00-05:00,TNXP,neutral
1244509.0,Tonix Pharma Files for a $34M Stock and Warrant Offering,2018-12-03 07:00:00-05:00,TNXP,neutral
1244510.0,52 Biggest Movers From Friday,2018-12-03 05:42:00-05:00,TNXP,neutral
1244511.0,"Most-Discussed Tickers In Benzinga Pro Chat For Morning Of Fri., Nov. 30, 2018",2018-11-30 12:34:00-05:00,TNXP,neutral
1244512.0,38 Stocks Moving In Friday's Mid-Day Session,2018-11-30 12:33:00-05:00,TNXP,neutral
1244513.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Fri., Nov. 30, 2018",2018-11-30 11:11:00-05:00,TNXP,positive
1244514.0,48 Biggest Movers From Yesterday,2018-11-30 05:39:00-05:00,TNXP,neutral
1244515.0,Mid-Afternoon Market Update: U.S. Stocks Turn Higher; Tilly's Shares Plunge,2018-11-29 14:42:00-05:00,TNXP,positive
1244516.0,32 Stocks Moving In Thursday's Mid-Day Session,2018-11-29 12:42:00-05:00,TNXP,neutral
1244517.0,Mid-Day Market Update: NASDAQ Down 1%; Tonix Pharmaceuticals Shares Spike Higher,2018-11-29 12:22:00-05:00,TNXP,positive
1244518.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Thurs., Nov. 29, 2018",2018-11-29 11:02:00-05:00,TNXP,positive
1244519.0,Mid-Morning Market Update: Markets Open Lower; Dollar Tree Issues Weak Guidance,2018-11-29 10:09:00-05:00,TNXP,negative
1244520.0,Tonix Pharma Rips Higher After FDA OKs Study Design For PTSD Drug,2018-11-29 09:58:00-05:00,TNXP,neutral
1244521.0,"UPDATE: Tonix Pharma Reports New Phase 3 RECOVERY Trial For Tonmya For PTSD To Include ~250 Participants, Trial Will Begin In Q1'19, Topline Data Expected 1H'20",2018-11-29 09:36:00-05:00,TNXP,neutral
1244522.0,Tonix Pharma shares are trading higher after the FDA communicated it is okay with the design of its Phase 3 trial for Tonmya.,2018-11-29 08:21:00-05:00,TNXP,positive
1244523.0,27 Stocks Moving In Thursday's Pre-Market Session,2018-11-29 08:02:00-05:00,TNXP,neutral
1244524.0,Tonix Pharma Reports Received Minutes From Breakthrough Therapy Guidance Meeting With FDA,2018-11-29 07:01:00-05:00,TNXP,neutral
1244525.0,40 Biggest Movers From Yesterday,2018-11-29 05:33:00-05:00,TNXP,neutral
1244526.0,36 Stocks Moving In Wednesday's Mid-Day Session,2018-11-28 12:19:00-05:00,TNXP,neutral
1244527.0,"Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018",2018-11-28 11:54:00-05:00,TNXP,negative
1244528.0,Tonix Pharmaceuticals Shares Halted On Circuit Breaker Again,2018-11-28 10:17:00-05:00,TNXP,positive
1244529.0,Tonix Pharmaceuticals Shares Resumed Trade At 10:01 a.m. ET,2018-11-28 10:04:00-05:00,TNXP,positive
1244530.0,Tonix Pharmaceuticals Shares Halted On Circuit Breaker,2018-11-28 09:52:00-05:00,TNXP,positive
1244531.0,"Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 26, 2018",2018-11-27 11:26:00-05:00,TNXP,negative
1244532.0,"Tonix Pharmaceuticals Reports 1-For-10 Reverse Stock Split, Effective Nov 28",2018-11-27 07:02:00-05:00,TNXP,positive
1244533.0,TONIX PHARM HLDG COR Q3 EPS $(0.57) Beats $(0.60) Estimate,2018-11-09 07:30:00-05:00,TNXP,neutral
1244534.0,Tonix Pharma shares are trading higher after the company announced a patent directed to pharmaceutical compositions of eutectics of cyclobenzaprine hydrochloride and mannitol which will provide the company with US exclusivity until 2034.,2018-11-07 09:34:00-05:00,TNXP,positive
1244535.0,Tonix Pharmaceuticals Announces New Patent Coverage Protecting Tonmya,2018-11-07 08:40:00-05:00,TNXP,neutral
1244536.0,82 Biggest Movers From Yesterday,2018-11-01 04:38:00-04:00,TNXP,neutral
1244537.0,"10 Hottest Stocks From October 31, 2018",2018-10-31 16:16:00-04:00,TNXP,neutral
1244538.0,66 Stocks Moving In Wednesday's Mid-Day Session,2018-10-31 12:50:00-04:00,TNXP,neutral
1244539.0,"Tonix Pharmaceuticals share are trading up 29.0% after the company announced plans to start Phase 3 trial of Tonmya, the company's treatment for PTSD, following FDA meeting.",2018-10-31 10:09:00-04:00,TNXP,positive
1244540.0,"Tonix Pharmaceuticals +39% Premarket; Co Announced Innovative Design in Next Phase 3 Study of Tonmya® for PTSD, Following FDA Meeting",2018-10-31 07:40:00-04:00,TNXP,positive
1244541.0,Tonix Pharmaceuticals will Present Phase 3 HONOR and Phase 2 AtEase Study Results in Poster Presentations at CNS Summit Nov 1-4,2018-10-29 07:35:00-04:00,TNXP,positive
1244542.0,"The Daily Biotech Pulse: FDA Nods For Adamis, Eli Lilly, Pfizer; Spero, Obseva Report Positive Trial Results",2018-09-28 08:10:00-04:00,TNXP,positive
1244543.0,"Stocks Which Set New 52-Week Low Yesterday, September 19th",2018-09-20 11:26:00-04:00,TNXP,negative
1244544.0,"Stocks Which Set New 52-Week Low Yesterday, September 17th",2018-09-18 09:27:00-04:00,TNXP,negative
1244545.0,"The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer Shares",2018-09-18 08:44:00-04:00,TNXP,positive
1244546.0,"Stocks Which Set New 52-Week Low Friday, September 14",2018-09-17 09:30:00-04:00,TNXP,negative
1244547.0,"Stocks Which Set New 52-Week Low Yesterday, September 13th",2018-09-14 09:30:00-04:00,TNXP,negative
1244548.0,"The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",2018-09-14 08:38:00-04:00,TNXP,neutral
1244549.0,"Stocks Which Set New 52-Week Low Yesterday, September 11th",2018-09-12 15:29:00-04:00,TNXP,negative
1244550.0,"The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet",2018-09-11 08:25:00-04:00,TNXP,negative
1244551.0,Tonix Pharmaceuticals Announces Director Samuel Saks Stepping Down,2018-08-22 16:03:00-04:00,TNXP,neutral
1244552.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Wed., Aug. 22, 2018",2018-08-22 09:25:00-04:00,TNXP,positive
1244553.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Tues., Aug. 21, 2018",2018-08-21 17:14:00-04:00,TNXP,positive
1244554.0,38 Stocks Moving In Tuesday's Mid-Day Session,2018-08-21 12:38:00-04:00,TNXP,neutral
1244555.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Tues., Aug. 21, 2018",2018-08-21 09:32:00-04:00,TNXP,positive
1244556.0,Benzinga Pro's 5 Stocks To Watch Today,2018-08-21 09:20:00-04:00,TNXP,neutral
1244557.0,Tonix Pharmaceuticals shares are up 15.2% premarket; The company is set to present trial results of Tonmya for military-related PTSD today at the 2018 Military Health System Research Symposium.,2018-08-21 08:57:00-04:00,TNXP,positive
1244558.0,"Tonix Pharmaceuticals Presents Results And Retrospective Analyses Of Two Double-Blind, Randomized Placebo-Controlled 12-Week Studies Of Tonmya In Military-Related PTSD At 2018 Military Health System Research Symposium",2018-08-21 07:10:00-04:00,TNXP,neutral
1244559.0,Tonix Pharmaceuticals Q2 EPS $(0.73) Beats $(0.80) Estimate,2018-08-13 07:10:00-04:00,TNXP,neutral
1244560.0,"Stocks Which Set New 52-Week Low Friday, July 27",2018-07-30 12:17:00-04:00,TNXP,negative
1244561.0,62 Biggest Movers From Friday,2018-07-30 04:16:00-04:00,TNXP,neutral
1244562.0,"Benzinga's Biggest Movers For The Week Of July 23, 2018",2018-07-27 16:00:00-04:00,TNXP,neutral
1244563.0,Mid-Afternoon Market Update: NASDAQ Down 1.7%; World Fuel Services Shares Gain Following Upbeat Q2 Results,2018-07-27 14:31:00-04:00,TNXP,positive
1244564.0,55 Stocks Moving In Friday's Mid-Day Session,2018-07-27 12:37:00-04:00,TNXP,neutral
1244565.0,Mid-Day Market Update: Essendant Rises After Q2 Results; Tonix Pharmaceuticals Shares Plunge,2018-07-27 12:01:00-04:00,TNXP,positive
1244566.0,B. Riley FBR Downgrades Tonix Pharmaceuticals to Neutral,2018-07-27 10:41:00-04:00,TNXP,neutral
1244567.0,Mid-Morning Market Update: Markets Mostly Lower; Twitter Shares Fall Following Q2 Results,2018-07-27 10:21:00-04:00,TNXP,neutral
1244568.0,"Tonix Pharma Shares Resume Trade, Pullback From Recent Highs, Down 16% Over Last Min.",2018-07-27 10:05:00-04:00,TNXP,positive
1244569.0,"Tonix Pharma Shares Halted On Circuit Breaker, Up 31% Over Last 10 Mins.; Shares Remain Down 64% For Session",2018-07-27 10:00:00-04:00,TNXP,positive
1244570.0,Roth Capital Downgrades Tonix Pharmaceuticals to Neutral,2018-07-27 09:55:00-04:00,TNXP,neutral
1244571.0,Tonix Pharmaceuticals Shares Down 77.2% After Co. Announced It Will Stop Phase 3 HONOR Study Of Tonmya For PTSD: Study Will Stop Due To Inadequate Separation From Placebo At Week 12 But Co. Said Decision To Discontinue Study Was Unrelated To Safety,2018-07-27 09:25:00-04:00,TNXP,positive
1244572.0,Benzinga Pro's 5 Stocks To Watch Today,2018-07-27 08:55:00-04:00,TNXP,neutral
1244573.0,Tonix Pharma To Resume Trade At 8:30 a.m. EDT,2018-07-27 08:26:00-04:00,TNXP,neutral
1244574.0,'I nominate this $TNXP headline/subhead for the Biotech Bamboozle Hall of Fame' -Tweet From STAT News' Adam Feuerstein,2018-07-27 08:07:00-04:00,TNXP,positive
1244575.0,UPDATE: Tonix Says Prelim. Safety Data From HONOR Study Participants 'did not reveal any serious and/or unexpected adverse events and the decision to discontinue the study is not related to safety',2018-07-27 08:06:00-04:00,TNXP,positive
1244576.0,UPDATE: Tonix Says Results For HONOR Study At Week 4 Showed Meaningful Clinical Improvement,2018-07-27 08:05:00-04:00,TNXP,positive
1244577.0,Tonix Pharma Reports Outcome Of Interim Analysis For Phase 3 HONOR Study Of Tonmya In Military-Related PTSD: Study Will Stop Due To Inadequate Separation From Placebo At Week 12,2018-07-27 08:05:00-04:00,TNXP,neutral
1244578.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Tues., Jul. 17, 2018",2018-07-17 15:27:00-04:00,TNXP,positive
1244579.0,40 Biggest Movers From Yesterday,2018-07-17 04:50:00-04:00,TNXP,neutral
1244580.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Jul. 16, 2018",2018-07-16 17:26:00-04:00,TNXP,positive
1244581.0,Tonix Shares Surge On Fast Struck Status For Alzheimer's-Related Agitation Candidate,2018-07-16 13:51:00-04:00,TNXP,negative
1244582.0,31 Stocks Moving In Monday's Mid-Day Session,2018-07-16 12:25:00-04:00,TNXP,neutral
1244583.0,Mid-Morning Market Update: Markets Mixed; Bank of America Profit Tops Expectations,2018-07-16 10:39:00-04:00,TNXP,positive
1244584.0,Benzinga Pro's 5 Stocks To Watch Today,2018-07-16 09:26:00-04:00,TNXP,neutral
1244585.0,Tonix Pharmaceuticals Shares Up 22% Premarket After Co. Received Fast-Track Designation From FDA For TNX-102 SL Treatment For Alzheimer's Agitation,2018-07-16 09:03:00-04:00,TNXP,positive
1244586.0,21 Stocks Moving In Monday's Pre-Market Session,2018-07-16 08:13:00-04:00,TNXP,neutral
1244587.0,Tonix Pharmaceuticals Receives Fast Track Designation from the U.S. FDA for TNX-102 SL for Treatment of Agitation in Alzheimer's Disease,2018-07-16 07:06:00-04:00,TNXP,negative
1244588.0,30 Biggest Movers From Yesterday,2018-07-10 05:02:00-04:00,TNXP,neutral
1244589.0,28 Stocks Moving In Monday's Mid-Day Session,2018-07-09 12:16:00-04:00,TNXP,neutral
1244590.0,40 Biggest Movers From Friday,2018-06-18 04:17:00-04:00,TNXP,neutral
1244591.0,40 Biggest Movers From Yesterday,2018-06-07 04:50:00-04:00,TNXP,neutral
1244592.0,28 Stocks Moving In Wednesday's Mid-Day Session,2018-06-06 12:24:00-04:00,TNXP,neutral
1244593.0,"Benzinga's Top Upgrades, Downgrades For June 6, 2018",2018-06-06 09:16:00-04:00,TNXP,positive
1244594.0,24 Stocks Moving In Wednesday's Pre-Market Session,2018-06-06 08:12:00-04:00,TNXP,neutral
1244595.0,"B. Riley FBR Initiates Coverage On Tonix Pharmaceuticals with Buy Rating, Announces $8 Price Target",2018-06-06 07:07:00-04:00,TNXP,neutral
1244596.0,Tonix Pharma Reports Prelim. Results From Phase 1 Pivotal Multiple-Dose Bridging Pharmacokinetic Study Of Tonmya Confirmed Applicability Of 505(b)(2) Regulatory Pathway NDA Approval,2018-05-24 07:08:00-04:00,TNXP,positive
1244597.0,Tonix Pharmaceuticals Q1 EPS $(0.88) Misses $(0.70) Estimate,2018-05-14 07:02:00-04:00,TNXP,negative
1244598.0,32 Stocks Moving In Tuesday's Mid-Day Session,2018-05-01 13:04:00-04:00,TNXP,neutral
1244599.0,21 Stocks Moving In Tuesday's Pre-Market Session,2018-05-01 08:32:00-04:00,TNXP,neutral
1244600.0,Benzinga Pro's 5 Stocks To Watch Today,2018-05-01 08:24:00-04:00,TNXP,neutral
1244601.0,Tonix Pharmaceuticals Receives IND Clearance by U.S. FDA for TNX-102 SL in Agitation in Alzheimer's Disease,2018-05-01 07:13:00-04:00,TNXP,negative
1244602.0,UPDATE: Tonix Pharma Says Interim Results Of HONOR Study Expected In Q3'18,2018-04-04 07:02:00-04:00,TNXP,positive
1244603.0,Tonix Pharma Reports Will Present FDA Breakthrough Therapy-Designated PTSD Program At MicroCap Conference; 'First 50% of Participants Enrolled in Phase 3 HONOR Study of Tonmya',2018-04-04 07:02:00-04:00,TNXP,positive
1244604.0,"Tonix Pharmaceuticals Achieves 50% Enrollment in Phase 3 Trial of FDA-Designated Breakthrough Therapy Tonmya, Topline Results Expected Q4 2018",2018-04-03 07:14:00-04:00,TNXP,neutral
1244605.0,"Tonix Pharma Reports Q4 EPS $(0.71) vs $(0.78) Est., No Sales",2018-03-12 07:13:00-04:00,TNXP,negative
1244606.0,40 Biggest Movers From Yesterday,2018-01-24 05:38:00-05:00,TNXP,neutral
1244607.0,33 Stocks Moving In Tuesday's Mid-Day Session,2018-01-23 12:50:00-05:00,TNXP,neutral
1244608.0,Benzinga Pro's 5 Stocks To Watch Today,2018-01-23 09:30:00-05:00,TNXP,neutral
1244609.0,28 Stocks Moving In Tuesday's Pre-Market Session,2018-01-23 08:02:00-05:00,TNXP,neutral
1244610.0,Tonix Pharma Awarded Patent for the Active Ingredient in Tonmya,2018-01-23 07:07:00-05:00,TNXP,positive
1244611.0,"Tonix Pharmaceuticals Announces Publication Reporting Synthesis, Construction and Characterization of a Potential Smallpox-Preventing Vaccine Candidate TNX-801",2018-01-19 14:00:00-05:00,TNXP,neutral
1244612.0,Tonix Pharmaceuticals Names Jessica Morris COO,2018-01-09 07:08:00-05:00,TNXP,neutral
1244613.0,30 Stocks Moving In Tuesday's Pre-Market Session,2017-12-12 08:09:00-05:00,TNXP,neutral
1244614.0,Tonix Pharmaceuticals Completes Positive Pre-IND Meeting with FDA for TNX-102 SL as a Clinical Candidate for Agitation in Alzheimer's Disease,2017-12-12 07:07:00-05:00,TNXP,positive
1244615.0,Tonix Pharmaceuticals Reports Q3 EPS $(0.77) vs $(0.70) Est.,2017-11-07 07:25:00-05:00,TNXP,neutral
1244616.0,Tonix Pharma Says its Proposed CMC Data Package to Support Tonmya's NDA was Accepted by the FDA Following a Guidance Meeting,2017-10-17 07:08:00-04:00,TNXP,positive
1244617.0,Tonix Pharma Shares Indicated Lower Premarket Following 8-K Filing Late Friday Showing Purchase Deal With Lincoln Park Capital For Sale Of Up To $15M In Co. Common Stock,2017-10-02 08:59:00-04:00,TNXP,neutral
1244618.0,30 Stocks Moving In Monday's Pre-Market Session,2017-10-02 08:11:00-04:00,TNXP,neutral
1244619.0,Tonix Pharmaceuticlas Receives European Pataent For Tonmya Active Ingredient,2017-09-14 16:07:00-04:00,TNXP,positive
1244620.0,Tonix Pharma Issues Release Highlighting PTSD Treatment 'Indicates Early Sleep Quality Improvements Correlate with Later Response to Treatment',2017-08-29 16:31:00-04:00,TNXP,positive
1244621.0,12 Biggest Mid-Day Gainers For Monday,2017-08-21 12:23:00-04:00,TNXP,neutral
1244622.0,"Benzinga's Top Upgrades, Downgrades For August 18, 2017",2017-08-18 09:19:00-04:00,TNXP,positive
1244623.0,Roth Capital Upgrades Tonix Pharmaceuticals to Buy,2017-08-18 08:01:00-04:00,TNXP,neutral
1244624.0,"Tonix Pharma Q2 EPS $(0.65) vs $(0.78) Est., No Sales",2017-08-14 07:09:00-04:00,TNXP,negative
1244625.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-08-02 08:14:00-04:00,TNXP,neutral
1244626.0,Tonix Pharma Expects to Report Topline Phase 3 HONOR Results in 2H 2018,2017-07-06 07:14:00-04:00,TNXP,positive
1244627.0,Tonix Pharmaceuticals Reports TNX-102 SL Phase 2 Results Poster,2017-05-22 16:15:00-04:00,TNXP,neutral
1244628.0,"Tonix Pharma Shares Rebound Off $4 Support Level Thurs., Gap Over $4.25, $4.50 Levels; Stock Up ~15.7% for Session",2017-05-19 10:09:00-04:00,TNXP,positive
1244629.0,Tonix Pharma Q1 EPS $(1.27) vs $(1.36) Est,2017-05-15 07:11:00-04:00,TNXP,neutral
1244630.0,"Tonix Pharma Reports Issuance of US Patent for TNX-102 SL Composition, Formulation",2017-05-02 07:05:00-04:00,TNXP,neutral
1244631.0,Shares Of Tonix Pharmaceuticals Volatile As Traders Circulating Old Post From Over A Month Ago Highlighting Tonix Developing Smallpox Vaccine,2017-04-20 11:14:00-04:00,TNXP,positive
1244632.0,13G from Opaleye Mgmt on Tonix Pharma Shows 5.52% Stake,2017-04-17 16:14:00-04:00,TNXP,neutral
1244633.0,Tonix Pharmaceuticals Reports Q4 EPS $(2.08) vs $(7.96) In Prior Year Period,2017-04-17 07:01:00-04:00,TNXP,neutral
1244634.0,16 Biggest Mid-Day Gainers For Tuesday,2017-04-11 12:45:00-04:00,TNXP,neutral
1244635.0,Tonix Pharmaceuticals +28% Premarket @$5.50 Following Reporting Results from FDA Meeting,2017-04-11 07:22:00-04:00,TNXP,neutral
1244636.0,Tonix Pharmaceuticals Says FDA Stated Single-Study NDA Approval Could Be Possible Based On Statistically Persuasive Topline Data,2017-04-11 07:02:00-04:00,TNXP,positive
1244637.0,13G from Empery Asset Mgmt on Tonix Pharma Shows New 5.28% Stake,2017-04-07 14:20:00-04:00,TNXP,positive
1244638.0,Adam Feuerstein Sees Major Price Manipulation In Small-Cap Pharma Stocks,2017-04-05 09:53:00-04:00,TNXP,negative
1244639.0,"Feuerstein Showing Concern with Investors/Traders Getting Involved in Pharma Names: 'Know What You're Buying,' Sees Co. Mgmts as Taking Advantage of Investors Left Holding the Bag",2017-04-05 08:56:00-04:00,TNXP,positive
1244640.0,"Feuerstein Discussing Tonix Pharma, Highlights is a Co. with 'A Really Checkered Past'",2017-04-05 08:54:00-04:00,TNXP,neutral
1244641.0,Tonix Pharmaceuticals Regains NASDAQ Compliance With Minimum Bid Price Requirement,2017-04-03 07:05:00-04:00,TNXP,neutral
1244642.0,15 Biggest Mid-Day Losers For Thursday,2017-03-30 13:03:00-04:00,TNXP,negative
1244643.0,20 Stocks Moving In Thursday's Pre-Market Session,2017-03-30 08:21:00-04:00,TNXP,neutral
1244644.0,Tonix Pharma Prices 1.8M Shares at $4.45/Share,2017-03-30 08:02:00-04:00,TNXP,positive
1244645.0,"Tonix Pharma Reports Offering of Common Stock, Amount Not Disclosed",2017-03-29 16:13:00-04:00,TNXP,neutral
1244646.0,18 Biggest Mid-Day Gainers For Wednesday,2017-03-29 12:46:00-04:00,TNXP,neutral
1244647.0,Mid-Day Market Update: Crude Oil Up 1.5%; Alliqua Biomedical Shares Slide,2017-03-29 12:13:00-04:00,TNXP,negative
1244648.0,Mid-Morning Market Update: Markets Mostly Lower; Paychex Profit Tops Views,2017-03-29 10:03:00-04:00,TNXP,positive
1244649.0,Tonix Pharma Shares Spike to $8.73 @ Open; Up 110%,2017-03-29 09:31:00-04:00,TNXP,positive
1244650.0,Tonix Pharma Shares Pullback as Traders Point Out Similar Language in Mar 7 PR for Roth Conference,2017-03-29 09:02:00-04:00,TNXP,positive
1244651.0,22 Stocks Moving In Wednesday's Pre-Market Session,2017-03-29 08:39:00-04:00,TNXP,neutral
1244652.0,Tonix Pharmaceuticals +16% Premarket @$4.82; Co to Present FDA Breakthrough Therapy-Designated PTSD Program at The MicroCap Conferenc,2017-03-29 07:49:00-04:00,TNXP,neutral
1244653.0,Tonix Pharmaceuticals Enrolls Initial Patient Into Military-Related PTSD Phase 3 Trial Of TNX-102 SL,2017-03-28 07:07:00-04:00,TNXP,neutral
1244654.0,Tonix Pharma Reports 1-for-10 Reverse Split,2017-03-16 13:00:00-04:00,TNXP,neutral
1244655.0,Tonix Pharmaceuticals Receives Notice of Allowance for New U.S. Patent Covering Composition and Manufacture of TNX-102,2017-03-14 07:08:00-04:00,TNXP,neutral
1244656.0,Tonix Pharmaceuticals  Reports Pre-Clinical Vaccine Activity In Synthesized Chimeric Horsepox Virus,2017-03-02 07:25:00-05:00,TNXP,neutral
1244657.0,15 Biggest Mid-Day Gainers For Monday,2016-12-19 12:43:00-05:00,TNXP,neutral
1244658.0,Mid-Day Market Update: Allied World Climbs On Acquisition News; JAKKS Pacific Shares Slide,2016-12-19 12:11:00-05:00,TNXP,positive
1244659.0,Mid-Morning Market Update: Markets Rise; Lennar Tops Q4 Estimates,2016-12-19 09:56:00-05:00,TNXP,positive
1244660.0,18 Stocks Moving In Monday's Pre-Market Session,2016-12-19 08:27:00-05:00,TNXP,neutral
1244661.0,Tonix Pharmaceuticals' PTSD Phase 3-Ready Drug Candidate TNX-102 SL Given Breakthrough Therapy Designation By FDA,2016-12-19 07:01:00-05:00,TNXP,neutral
1244662.0,Tonix Pharmaceuticals Presented New Clinical Results from Sub-Group Analysis of Phase 2 AtEase Study in Military-Related Posttraumatic Stress Disorder,2016-12-08 07:05:00-05:00,TNXP,negative
1244663.0,13G from Rosalind Advisors on Tonix Pharma Shows New 5.7% Stake,2016-11-30 13:07:00-05:00,TNXP,neutral
1244664.0,"TNXP Tonix Pharmaceuticals Holding Corp.: MARIO ERNEST (Director) Buys 120,000 @ Avg Price: $0.41 (Form4)",2016-11-28 11:36:00-05:00,TNXP,neutral
1244665.0,"Tonix Pharmaceuticals Holding Corp.: LEDERMAN SETH (Director,Chief Executive Officer) Buys 98,000 @ Avg Price: $0.43",2016-11-22 16:26:00-05:00,TNXP,neutral
1244666.0,Tonix Pharma Reports Q3 EPS $(0.29) vs $(0.34) Est.,2016-11-10 16:30:00-05:00,TNXP,neutral
1244667.0,Tonix Pharmaceuticals To Present Clinical Data At CNS Summit Oct. 27-30,2016-10-27 16:33:00-04:00,TNXP,neutral
1244668.0,"Tonix Pharma Prices 9.5M Units, Warrants for 4.75M Shares of Common Stock at $0.55/Unit",2016-10-26 08:47:00-04:00,TNXP,positive
1244669.0,"Tonix Pharma Reports Offering of Common Shares, Warrants, No Quantity/Size Disclosed",2016-10-25 17:15:00-04:00,TNXP,neutral
1244670.0,Tonix Pharmaceuticals Spikes to High of $0.82 on Volume,2016-10-04 11:20:00-04:00,TNXP,neutral
1244671.0,Stocks Hitting 52-Week Lows,2016-09-19 10:27:00-04:00,TNXP,negative
1244672.0,15 Biggest Mid-Day Losers For Wednesday,2016-09-07 13:21:00-04:00,TNXP,negative
1244673.0,7 Biggest Price Target Changes For Wednesday,2016-09-07 09:48:00-04:00,TNXP,neutral
1244674.0,Benzinga's Top Downgrades,2016-09-07 09:02:00-04:00,TNXP,positive
1244675.0,Roth Capital Downgrades Tonix Pharmaceuticals to Neutral,2016-09-07 08:41:00-04:00,TNXP,neutral
1244676.0,Cantor Fitzgerald Downgrades Tonix Pharmaceuticals to Hold,2016-09-07 07:23:00-04:00,TNXP,neutral
1244677.0,Mid-Afternoon Market Update: Gold Futures Up 2%; CoLucid Shares Climb After Migraine Drug Achieves Primary And Key Secondary Endpoints,2016-09-06 14:33:00-04:00,TNXP,positive
1244678.0,10 Biggest Mid-Day Losers For Tuesday,2016-09-06 13:03:00-04:00,TNXP,negative
1244679.0,Mid-Day Market Update: Navistar Rises After Strategic Alliance With Volkswagen Truck & Bus; Tonix Shares Drop,2016-09-06 12:08:00-04:00,TNXP,neutral
1244680.0,Stocks Hitting 52-Week Lows,2016-09-06 10:25:00-04:00,TNXP,negative
1244681.0,Mid-Morning Market Update: Markets Open Higher; Danaher To Acquire Cepheid For $4B,2016-09-06 10:05:00-04:00,TNXP,neutral
1244682.0,15 Stocks Moving In Tuesday's Pre-Market Session,2016-09-06 08:22:00-04:00,TNXP,neutral
1244683.0,Tonix Pharmaceuticals Misses Primary Efficacy Endpoint,2016-09-06 07:04:00-04:00,TNXP,negative
1244684.0,15 Biggest Mid-Day Gainers For Monday,2016-08-29 12:40:00-04:00,TNXP,neutral
1244685.0,Tonix Announces Successful End-of-Phase 2 Meeting with FDA For PTSD Drug,2016-08-29 10:34:00-04:00,TNXP,positive
1244686.0,10 Stocks Moving In Monday's Pre-Market Session,2016-08-29 08:21:00-04:00,TNXP,neutral
1244687.0,Tonix Pharmaceuticals +14.75% Premarket @$2.80; Co Announced Successful 'End of Phase 2 Meeting' With FDA,2016-08-29 07:58:00-04:00,TNXP,positive
1244688.0,Tonix Pharma Says FDA Has Accepted Phase 3 Study,2016-08-29 07:02:00-04:00,TNXP,positive
1244689.0,15 Biggest Mid-Day Gainers For Monday,2016-08-08 12:43:00-04:00,TNXP,neutral
1244690.0,11 Stocks Moving In Monday's Pre-Market Session,2016-08-08 08:26:00-04:00,TNXP,neutral
1244691.0,Tonix Pharmaceuticals Begins Second Pivotal Phase 3 Clinical Study of TNX-102 SL in Fibromyalgia,2016-07-26 08:06:00-04:00,TNXP,neutral
1244692.0,"Chairman Lederman Buys 20,000 Shares of Tonix Pharmaceuticals  @$2.08/Share -Form 4",2016-06-22 17:24:00-04:00,TNXP,positive
1244693.0,NOTE: Tonix Pharma Announced 5M Share Offering Priced @ $2/Share on June 16,2016-06-21 12:56:00-04:00,TNXP,positive
1244694.0,"Chairman Lederman Buys 25,000 Shares of Tonix Pharmaceuticals @$2.00/Share -Form 4",2016-06-21 12:51:00-04:00,TNXP,positive
1244695.0,Tonix Pharmaceuticals Spikes to High of $2.02; Multiple Insider Buys Reported on Form 4s,2016-06-21 12:48:00-04:00,TNXP,neutral
1244696.0,"Officer Daugherty Buys 100,000 Shares of Tonix Pharmaceuticals @$2.00/Share -Form 4",2016-06-21 12:45:00-04:00,TNXP,positive
1244697.0,Mid-Afternoon Market Update: Dow Turns Positive; Korn/Ferry Shares Slide,2016-06-16 14:30:00-04:00,TNXP,positive
1244698.0,9 Biggest Mid-Day Losers For Thursday,2016-06-16 12:45:00-04:00,TNXP,negative
1244699.0,Mid-Day Market Update: Crude Oil Down Over 3%; QLogic Shares Surge Following Acquisition News,2016-06-16 12:07:00-04:00,TNXP,negative
1244700.0,Mid-Morning Market Update: Markets Open Lower; Kroger Profit Tops Views,2016-06-16 10:07:00-04:00,TNXP,positive
1244701.0,10 Stocks Moving In Thursday's Pre-Market Session,2016-06-16 08:21:00-04:00,TNXP,neutral
1244702.0,Tonix Pharma Prices 5M Shares at $2/Share,2016-06-16 08:01:00-04:00,TNXP,positive
1244703.0,Tonix Pharmaceuticals Reports Proposed Public Offering of Common Stock,2016-06-15 16:01:00-04:00,TNXP,neutral
1244704.0,Tonix Pharmaceuticals Presents at EULAR Results of a Retrospective Analysis from the Phase 2b BESTFIT Clinical Study of TNX-102 SL in Fibromyalgia,2016-06-09 10:30:00-04:00,TNXP,neutral
1244705.0,Cantor Fitzgerald Upgrades Tonix Pharmaceuticals to Buy,2016-06-02 08:23:00-04:00,TNXP,neutral
1244706.0,11 Stocks Moving In Thursday's Pre-Market Session,2016-06-02 08:21:00-04:00,TNXP,neutral
1244707.0,Today's Top 10 Pre-Market Gainers,2016-05-31 09:28:00-04:00,TNXP,positive
1244708.0,Tonix Pharmaceuticals To Present PTSD Phase 2 AtEase Study Data At ASCP Meeting,2016-05-31 07:04:00-04:00,TNXP,neutral
1244709.0,Tonix Pharma To Show Positive Phase 2 AtEase Study Of TNX-102 At ASCP May 30th-June 3rd,2016-05-26 08:33:00-04:00,TNXP,positive
1244710.0,Tonix Pharmaceuticals Issues Investor Presentation,2016-05-25 09:59:00-04:00,TNXP,neutral
1244711.0,15 Stocks Moving In Thursday's Pre-Market Session,2016-05-19 08:16:00-04:00,TNXP,neutral
1244712.0,Tonix Pharmaceuticals Reports Topline Results from Phase 2 AtEase Study of TNX-102,2016-05-19 06:03:00-04:00,TNXP,neutral
1244713.0,Tonix Pharma Q1 EPS ($0.74) vs ($0.63) est,2016-05-09 07:14:00-04:00,TNXP,neutral
1244714.0,"Tonix Pharmaceuticals Reports Cash, Cash Equivalents, Marketable Securities at December 31, 2015 of $43M",2016-05-02 07:16:00-04:00,TNXP,positive
1244715.0,Tonix Pharmaceuticals Releases Investor Presentation,2016-05-02 07:12:00-04:00,TNXP,neutral
1244716.0,"Director Mario Buys 75,000 Shares of Tonix Pharmaceuticals @$2.29/Share -Form 4",2016-03-17 07:13:00-04:00,TNXP,positive
1244717.0,"Tonix Pharmaceuticals Data Shows Increased Plasma Levels of 338% During First Hour, 83% After 2 Hourts At ASCPT 2016 Annual Meeting",2016-03-09 07:02:00-05:00,TNXP,positive
1244718.0,Tonix Pharma Reports Q4 EPS $(0.71) vs $(0.66) Est.,2016-03-04 07:01:00-05:00,TNXP,neutral
1244719.0,Tonix Pharmaceuticals Appoints CFO,2016-02-25 16:55:00-05:00,TNXP,neutral
1244720.0,"Oppenheimer Maintains Outperform on Tonix Pharmaceuticals, Lowers PT to $10.00",2016-02-17 08:12:00-05:00,TNXP,negative
1244721.0,Cantor Fitzgerald Downgrades Tonix Pharmaceuticals to Speculative Buy,2016-02-17 07:52:00-05:00,TNXP,positive
1244722.0,Mid-Afternoon Market Update: Dow Jumps 200 Points; Community Health Systems Shares Drop On Downbeat Results,2016-02-16 14:33:00-05:00,TNXP,neutral
1244723.0,Mid-Day Market Update: ADT Surges On Acquisition News; Gogo Shares Slide,2016-02-16 12:01:00-05:00,TNXP,positive
1244724.0,Stocks Hitting 52-Week Lows,2016-02-16 10:10:00-05:00,TNXP,negative
1244725.0,Mid-Morning Market Update: Markets Open Higher; Hormel Foods Raises Full-Year Forecast,2016-02-16 10:05:00-05:00,TNXP,neutral
1244726.0,Tonix Pharmaceuticals - 38% Premarket @$2.50 Following Report of Failed TNX-201 Results,2016-02-16 08:33:00-05:00,TNXP,negative
1244727.0,UPDATE: Tonix Pharmaceuticals Says Study Did Not Achieve Its Primary Efficacy Endpoint Plus Two Other Primary Endpoints; TNX-201 Program to be Discontinued,2016-02-16 08:06:00-05:00,TNXP,neutral
1244728.0,7 Biotech Traders Pick Their Favorite Stocks For 2016,2016-01-28 16:53:00-05:00,TNXP,positive
1244729.0,Tonix Pharma Names Chief Admin Officer Jessica Edgar Morris Acting CFO,2016-01-08 16:06:00-05:00,TNXP,neutral
1244730.0,Tonix Pharma Reports Closing of Enrollment for Phase 2 Trial of TNX-102 SL in PTSD,2015-12-23 07:01:00-05:00,TNXP,neutral
1244731.0,"Tonix Pharma Finds Resistance In Familiar Area, Just Under $7.00 Level",2015-12-15 14:06:00-05:00,TNXP,neutral
1244732.0,Tonix Pharmaceuticals Completes Enrollment in Phase 2 Clinical Study of TNX-201 in Episodic Tension-Type Headache,2015-12-08 07:01:00-05:00,TNXP,neutral
1244733.0,Tonix Pharmaceuticals and U.S. Department of Defense Military Developer in Partnership to Expand Efforts to Examine TNX-102 SL for Post-Traumatic Stress Disorder,2015-12-07 07:01:00-05:00,TNXP,negative
1244734.0,"Tonix Pharmaceuticals Presents Additional Data on Tonmya(TM) Demonstrating Improvements in Sleep, Pain, and Other Outcomes in Fibromyalgia at 2015 ACR/ARHP Annual Meeting",2015-11-10 08:31:00-05:00,TNXP,negative
1244735.0,Tonix Pharmaceuticals Reports Q3 EPS $(0.72) vs. Est. $(0.62),2015-11-09 07:08:00-05:00,TNXP,neutral
1244736.0,Tonix Pharmaceuticals Announces Acceptance of Three Abstracts to be Presented at the 2015 ACR/ARHP Annual Meeting,2015-10-01 07:04:00-04:00,TNXP,positive
1244737.0,"Tonix Pharmaceuticals Officer Sullivan Buys 4,694 Shares @$5.95/Share -Form 4",2015-09-28 13:26:00-04:00,TNXP,positive
1244738.0,"Tonix Pharmaceuticals Director Mario Buys 10,000 Shares @$6.05/Share -Form 4",2015-08-27 15:14:00-04:00,TNXP,positive
1244739.0,Tonix Pharma Q2 EPS -$0.73 vs -$0.65 est,2015-08-10 07:03:00-04:00,TNXP,neutral
1244740.0,"Tonix Pharmaceuticals Names Mark T. Edgar, PhD as Senior VP of Product Development",2015-07-21 07:09:00-04:00,TNXP,neutral
1244741.0,"Tonix Pharmaceuticals Appoints Mark T. Edgar, PhD as Senior Vice President of Product Development",2015-07-21 07:05:00-04:00,TNXP,neutral
1244742.0,"Tonix Pharmaceuticals Director Saks Buys 10,000 Shares @$7.50/Share -Form 4",2015-07-17 15:38:00-04:00,TNXP,positive
1244743.0,Mid-Afternoon Market Update: Micron Gains On Rumor Of Tsinghua Bid; Navient Shares Drop,2015-07-14 15:14:00-04:00,TNXP,positive
1244744.0,Mid-Day Market Update: Vince Holding Declines After CEO Resignation; Natural Health Trends Shares Surge,2015-07-14 12:49:00-04:00,TNXP,positive
1244745.0,"Tuesday's Mid-Day Movers: Iran's Nuclear Deal Reached; Micron Technology Bid, Box Inc And More",2015-07-14 12:31:00-04:00,TNXP,positive
1244746.0,Mid-Morning Market Update: Markets Rise; JPMorgan Earnings Beat Views,2015-07-14 10:21:00-04:00,TNXP,neutral
1244747.0,Morning Market Losers,2015-07-14 09:47:00-04:00,TNXP,negative
1244748.0,"Tonix Pharmaceuticals Prices Underwritten Public Offering of Common Stock, 2.325M Shares At $7.50/Shr",2015-07-14 08:32:00-04:00,TNXP,positive
1244749.0,Tonix Pharmaceuticals Prices 2.325M Offering At $7.50/Share,2015-07-14 08:31:00-04:00,TNXP,neutral
1244750.0,Tonix Pharmaceutical Reports Proposed Offering,2015-07-13 16:02:00-04:00,TNXP,neutral
1244751.0,"Tonix Pharmaceuticals Says Top Line Results from Atease Trial, to Evaluate TNX-102 Sl for Treatment of Post-Traumatic Stress Disorder Expected in H1 2016 -8-K",2015-06-29 06:13:00-04:00,TNXP,negative
1244752.0,Tonix Pharmaceuticals Presents Non-clinical Data on TNX-201 at the 57th Annual Scientific Meeting of the American Headache Society,2015-06-22 08:01:00-04:00,TNXP,neutral
1244753.0,US Stock Futures Up; All Eyes On Fed Decision,2015-06-17 07:29:00-04:00,TNXP,neutral
1244754.0,"Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya as Proposed Brand Name for Cyclobenzaprine HCl Sublingual Tablets, 2.8 mg",2015-06-17 07:18:00-04:00,TNXP,positive
1244755.0,Tonix Pharmaceuticals Initiates Phase 2 Clinical Study of TNX-201 in Episodic Tension-Type Headache,2015-06-16 07:16:00-04:00,TNXP,neutral
1244756.0,Oppenheimer: Time To Buy Tonix Pharmaceuticals,2015-06-14 10:51:00-04:00,TNXP,neutral
1244757.0,Morning Market Gainers,2015-06-12 09:49:00-04:00,TNXP,neutral
1244758.0,Benzinga's Top Initiations,2015-06-12 09:19:00-04:00,TNXP,positive
1244759.0,Benzinga's Top #PreMarket Gainers,2015-06-12 08:20:00-04:00,TNXP,positive
1244760.0,"CORRECTION: Oppenheimer Initiates Coverage on Tonix Pharmaceuticals at Outperform, Announces $18.00 PT",2015-06-12 08:05:00-04:00,TNXP,neutral
1244761.0,Tonix Pharma Says TNX-102 Was Well Tolerate in Study,2015-06-11 07:08:00-04:00,TNXP,positive
1244762.0,Tonix Pharmaceuticals to Showcase Additional Data From Finished Phase 2b Study of TNX-102 SL in Fibromyalgia at EULAR,2015-05-20 07:02:00-04:00,TNXP,neutral
1244763.0,Tonix Pharmaceuticals Begins Phase 3 Clinical Study Of TNX-102 SL in Fibromyalgia,2015-05-13 06:02:00-04:00,TNXP,neutral
1244764.0,Tonix Pharma Q1 EPS -$0.71 vs -$0.54 est,2015-05-11 06:03:00-04:00,TNXP,neutral
1244765.0,Analyst Sees Success For Tonix Pharmaceuticals Holdings Corp.,2015-05-07 16:43:00-04:00,TNXP,positive
1244766.0,Benzinga's Top Initiations,2015-05-07 10:03:00-04:00,TNXP,positive
1244767.0,Janney Capital Initiates Tonix Pharmaceuticals At Buy,2015-05-07 09:51:00-04:00,TNXP,neutral
1244768.0,"Janney Capital Initiates Coverage on Tonix Pharmaceuticals at Buy, Announces $10.00 PT",2015-05-07 06:10:00-04:00,TNXP,neutral
1244770.0,Tonix Pharmaceuticals Shares Rise 5.5% Premarket; May be Attributed to Seeking Alpha Post,2015-04-21 08:27:00-04:00,TNXP,positive
1244771.0,"Tonix Pharmaceuticals Chairman Lederman Buys 2,000 Shares @$6.95/Share -Form 4",2015-03-11 13:39:00-04:00,TNXP,positive
1244772.0,Tonix Pharma Holding Reports Q4 EPS -$0.83 Vs Est -$0.81,2015-03-03 08:01:00-05:00,TNXP,neutral
1244773.0,Tonix Pharmaceuticals Prices 4.9M Share Offering @$5.85/Share,2015-02-04 08:15:00-05:00,TNXP,positive
1244774.0,Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock,2015-02-03 16:22:00-05:00,TNXP,neutral
1244775.0,Roth Capital's 4 Reasons To Be Bullish On Titan Pharmaceuticals,2015-01-26 17:44:00-05:00,TNXP,neutral
1244776.0,Tonix Pharma Reports Commencement of Phase 2 Trial of TNX-102 SL in PTSD,2015-01-15 07:04:00-05:00,TNXP,neutral
1244777.0,Tonix Pharma Announces Positive Progress on Trials,2015-01-09 07:05:00-05:00,TNXP,positive
1244778.0,Morning Market Movers,2015-01-06 09:50:00-05:00,TNXP,neutral
1244779.0,Tonix Pharmaceuticals Provides Clinical and Regulatory Update on its Continued Development of TNX-102 SL in Fibromyalgia,2015-01-06 07:04:00-05:00,TNXP,neutral
1244780.0,TONIX PHARM HLDG COR Reports Q3 EPS of $(0.71) vs $(0.69) Est,2014-11-10 08:42:00-05:00,TNXP,neutral
1244781.0,Tonix Pharma Reports Receiving IND Clearance for TNX-201 in Episodic Tension-Type Headache,2014-10-21 08:41:00-04:00,TNXP,neutral
1244782.0,Benzinga's Top #PreMarket Losers,2014-09-30 08:13:00-04:00,TNXP,negative
1244783.0,"Midday Losers From September 29 - Tonix Pharmaceuticals Holding Corp., Digital Ally, Inc. And More",2014-09-29 13:58:00-04:00,TNXP,negative
1244784.0,Morning Market Losers ,2014-09-29 09:48:00-04:00,TNXP,negative
1244785.0,Benzinga's Top #PreMarket Losers,2014-09-29 08:18:00-04:00,TNXP,negative
1244786.0,Tonix Pharmaceuticals Reports Phase 2b BESTFIT Trial of TNX-102 SL in Patients With Fibromyalgia Did Not Meet Primary Endpoint,2014-09-29 06:15:00-04:00,TNXP,neutral
1244787.0,Tonix Pharma Reports Transfer of Listing to NASDAQ Exchange,2014-08-11 08:40:00-04:00,TNXP,neutral
1244788.0,TONIX PHARM HLDG COR Reports Q2 EPS of $(0.61) vs $(0.53) Est,2014-08-08 16:06:00-04:00,TNXP,neutral
1244789.0,Tonix Pharma Prices 657K Shares at $11.90/Share,2014-07-11 08:21:00-04:00,TNXP,positive
1244790.0,Benzinga's Volume Movers,2014-06-23 10:30:00-04:00,TNXP,neutral
1244791.0,Tonix Pharma Announces Has Received FDA IND Clearance for TNX-102 SL for PTSD,2014-06-10 08:34:00-04:00,TNXP,neutral
1244792.0,Tonix Pharma Names Gregory Sullivan as Chief Medical Officer,2014-06-03 09:05:00-04:00,TNXP,neutral
1244793.0,TONIX PHARM HLDG COR Reports Q1 EPS of $(0.59) vs $(0.35) Est,2014-05-13 17:01:00-04:00,TNXP,neutral
1244794.0,Tonix Completes Enrollment for Trial of TNX-102,2014-05-12 08:43:00-04:00,TNXP,neutral
1244795.0,"Tonix Pharma Names Donald Kellerman as Senior VP, Clinical Development, Regulatory Affairs",2014-04-01 08:47:00-04:00,TNXP,neutral
1244796.0,TONIX PHARM HLDG COR Reports Q4 EPS of $(0.74) vs $(0.46) Est,2014-03-31 09:15:00-04:00,TNXP,neutral
1244797.0,"Tonix Pharma Closes Pre-IND Meeting with FDA on TNX-201, Says Clinical Development to Begin in Q4'14",2014-03-03 09:41:00-05:00,TNXP,neutral
1244798.0,Tonix Pharma Closes Offering of 2.9M Shares at $15/Share for Gross Proceeds $43.5M,2014-01-29 11:16:00-05:00,TNXP,negative
1244799.0,"Tonix Pharma Prices 2.9M Shares at $15/Share, Expecting Net Proceeds $40.7M",2014-01-24 08:21:00-05:00,TNXP,positive
1244800.0,UPDATE: Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock,2014-01-23 16:21:00-05:00,TNXP,neutral
1244801.0,Tonix Pharma Announces Common Stock Offering ,2014-01-23 16:03:00-05:00,TNXP,neutral
1244802.0,Morning Market Losers ,2013-12-11 10:05:00-05:00,TNXP,negative
1244803.0,TONIX PHARM HLDG COR Reports Q3 EPS of $(0.87) vs $(0.64) Est,2013-11-13 16:14:00-05:00,TNXP,neutral
1244804.0,"Roth Capital Initiates Coverage on TONIX PHARM HLDG COR at Buy, Announces $8.50 PT",2013-10-01 08:23:00-04:00,TNXP,neutral
1244805.0,Tonix Pharmaceuticals Announces Pricing of Public Offering of Units and NASDAQ Listing ,2013-08-09 08:37:00-04:00,TNXP,neutral
1244806.0,Tonix Pharmaceuticals Receives FDA Clearance to Initiate a Pharmacokinetic Study of TNX-102 For Fibromyalgia,2011-11-18 07:30:00-05:00,TNXP,neutral
